Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Pharmacy Services Aid CVS Health, Aetna Deal An Upside Too By Zacks Investment Research - Feb 14, 2018

On Feb 13, we issued an updated research report on CVS Health Corporation (NYSE:CVS) . The company carries a Zacks Rank #3 (Hold).This leading provider of integrated services across the entire...

Zacks Investment Research
Annaly Capital (NLY) Q4 Earnings Beat Estimates, NII Grows By Zacks Investment Research - Feb 14, 2018

Annaly Capital Management, Inc. (NYSE:NLY) reported fourth-quarter 2017 adjusted core earnings of 31 cents per share, beating the Zacks Consensus Estimate by a penny. Also, earnings compared...

Zacks Investment Research
Leveraged ETFs To Bet On Market Rebound For Big Gains By Zacks Investment Research - Feb 14, 2018

After a vicious selloff last week, the Wall Street is back in the green for the year, bouncing back strongly from their lowest level, which had sent the major indices to a correction territory. Major...

Harry Boxer
5 Momentum Charts To Watch: CBAY, HTGM, MIME, MTCH, TWTR By Harry Boxer - Feb 14, 2018

Cymabay Therapeutics, Inc. (NASDAQ:CBAY) reached a new all-time high of $13.79 Tuesday before ending the session up 10%, or $1.25, at $13.50 on very heavy volume of 2.6 million shares traded. The move...

Harry Boxer
4 Stocks To Watch: CLVS, HTGM, MTCH, TWTR By Harry Boxer - Feb 14, 2018

Clovis Oncology Inc (NASDAQ:CLVS) was up 1.70, or 3.2%, to 54.76, on 1.2 million shares traded on Tuesday. I believe it completed four waves down and is at support going back a year. More importantly,...

Zacks Investment Research
Battered Blue Chips: Value Stocks Or Traps? By Zacks Investment Research - Feb 14, 2018

Welcome to Episode #81 of the Value Investor Podcast Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio service, shares some of her top value investing tips and stock picks. The...

Zacks Investment Research
Initial Claims, PPI Data In Focus By Zacks Investment Research - Feb 14, 2018

Ahead of Thursday’s opening bell, a slew of new economic data has hit the tape to inform market futures. Aside from the normal Thursday Initial Jobless Claims, we also see index reports from...

Zacks Investment Research
Marriott (MAR) Q4 Earnings And Revenues Surpass Estimates By Zacks Investment Research - Feb 14, 2018

Marriott International, Inc. (NASDAQ:MAR) reported better-than-expected fourth-quarter 2017 results.Adjusted earnings per share of $1.12 surpassed the Zacks Consensus Estimate by 12 cents and...

Zacks Investment Research
Ralph Lauren's (RL) Strategies Look Appeasing: Time To Buy? By Zacks Investment Research - Feb 14, 2018

Shares of Ralph Lauren Corporation (NYSE:RL) have been flying high on its strategic initiatives, Way Forward Plan & Restructuring Activities and robust earnings surprise history. In fact, the...

Zacks Investment Research
Andersons (ANDE) Q4 Earnings Top Despite Tough Markets By Zacks Investment Research - Feb 14, 2018

The Andersons, Inc.’s (NASDAQ:ANDE) fourth-quarter 2017 adjusted earnings surged around 72% year over year to 62 cents per share. Earnings also beat the Zacks Consensus Estimate of 38 cents...

Zacks Investment Research
New Data Salad Informs Market: PPI, Jobless Claims, Etc. By Zacks Investment Research - Feb 14, 2018

Thursday, February 15, 2018Ahead of Thursday’s opening bell, a slew of new economic data has hit the tape to inform market futures. Aside from the normal Thursday Initial Jobless Claims, we also...

Zacks Investment Research
Pilgrim's Pride (PPC) Tops Q4 Earnings & Revenue Estimates By Zacks Investment Research - Feb 14, 2018

Premium consumer goods company Pilgrim's Pride Corporation (NASDAQ:PPC) reported better-than-expected results for fourth-quarter 2017.Earnings The company’s quarterly earnings of 54 cents per...

Continue with Apple
Continue with Google
or
Sign up with Email